Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard carePallav L. Shah, Dilys Lai, Brenda Crabtree‐Ramírez et al.|The Lancet Respiratory Medicine|2022Cited by 58
A randomised controlled trial of early intervention with oral favipiravir in patients hospitalised with COVID-19 (PIONEER Trial)Christopher M. Orton, Michael Pelly, Pallav L. Shah et al.|10.01 - Respiratory infections and bronchiectasis|2022Cited by 1